Predictors of Prognosis in IBD Patients
Recruiting · NCT05653011 · Observational (researchers observe without assigning treatment) · Lead sponsor: Seoul National University Bundang Hospital
View the official record on ClinicalTrials.gov →Interventions studied
Endoscopic biopsy
What this trial is about
A study of clinical characteristics and potential prognostic factors in inflammatory bowel disease
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- control group: Patients who do not have colitis, cancer, and advanced polyp (the number of polyps ≥ 3, the size of polyps ≥ 1cm, high-grade adenoma, villous adenoma)
- TNF-α inhibitor-naive IBD group: IBD patients who do not have a history of TNF-α inhibitor treatment
- TNF-α inhibitor-treated IBD group: IBD patients who are treated with TNF-α inhibitor
Exclusion criteria
- Age under 18 years
- Patients who were treated with antibiotics or probiotics within the last 3 months
Where it is running
2 locations listed.
- Seoul National University Bundang Hospital - Seongnam-si, Gyeonggi-do, South Korea
- Seoul National University Bundang Hospital - Seongnam-si, Gyeonggi-do, South Korea